Sartorius Stedim Biotech SA: Information on Document Availability
Sartorius Stedim Biotech Group’s Universal Registration Document 2022 is now available at:
- Sartorius Stedim Biotech Group’s Universal Registration Document 2022 is now available at:
It contains the following information:
- Consolidated financial statements for the year ended December 31, 2022
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. - As a total solutions provider, the company helps its customers to manufacture biotech medications safely, rapidly and economically.
- Headquartered in Aubagne, France, the shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris.
- With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach.